Catalyst Wire Dossier Catalyst Wire Dossier

Rhu-plasma Gelsolin

rhu-plasma gelsolin · BioAegis Therapeutics Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Rhu-plasma Gelsolin, covering 2020-01-27 to 2020-01-27. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1b/2a Study of the Safety and Pharmacokinetics of Rhu-plasma Gelsolin in Hospitalized Subjects With CAP [Phase 1, Phase 2]

See pricing